← Open Payments lookup

ERICA HAN: Open Payments

NPI 1073806022 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,303 in 61 payments from 14 companies in 2025. Trend: 2023 $3,502 · 2024 $696 · 2025 $1,303

Food & beverage: $1,269Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$346
Regeneron Healthcare Solutions, Inc.9$200
Takeda Pharmaceuticals U.S.A., Inc.6$173
GlaxoSmithKline, LLC.10$169
ARS Pharmaceuticals Operations, Inc.13$142
Optinose US, Inc.2$50
Amgen Inc.2$48
Novartis Pharmaceuticals Corporation2$47
GENZYME CORPORATION1$32
Galderma Laboratories, L.P.1$26

Products named: DUPIXENT, TEZSPIRE, NUCALA, CUVITRU, NEFFY, FASENRA, Xhance, AIRSUPRA.

Industry payments across TX — which companies pay providers there.